Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.530
-0.040 (-1.56%)
At close: Jun 18, 2026, 4:00 PM EDT
2.480
-0.050 (-1.98%)
After-hours: Jun 18, 2026, 5:02 PM EDT
Kiora Pharmaceuticals Employees
Kiora Pharmaceuticals had 13 employees as of December 31, 2025. The number of employees increased by 1 or 8.33% compared to the previous year.
Employees
13
Change (1Y)
1
Growth (1Y)
8.33%
Revenue / Employee
n/a
Profits / Employee
-$850,781
Market Cap
11.21M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13 | 1 | 8.33% |
| Dec 31, 2024 | 12 | 0 | - |
| Dec 31, 2023 | 12 | 0 | - |
| Dec 31, 2022 | 12 | -2 | -14.29% |
| Dec 31, 2021 | 14 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioCardia | 21 |
| SeaStar Medical Holding | 17 |
| Theriva Biologics | 16 |
| CalciMedica | 16 |
| BioRestorative Therapies | 14 |
| Intensity Therapeutics | 7 |
| Phio Pharmaceuticals | 6 |
| Akari Therapeutics, | 6 |
KPRX News
- 2 days ago - Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model - Newsfile Corp
- 4 days ago - Kiora Pharmaceuticals Slides: Corporate presentation - Filings
- 4 weeks ago - Kiora Pharmaceuticals files to sell 11.8M shares of common stock for holders - TheFly
- 4 weeks ago - Kiora Pharmaceuticals Registration statement: Registration filing - Filings
- 6 weeks ago - Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update - Newsfile Corp
- 6 weeks ago - Kiora Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Kiora Pharmaceuticals Earnings release: Q1 2026 - Filings
- 7 weeks ago - Kiora Pharmaceuticals Proxy statement: Proxy filing - Filings